Psychiatric Specialists of Texas - Laredo
6548 Springfield Avenue, 202, Laredo
United States
1 listed treatment center serving Laredo and the surrounding area.
6548 Springfield Avenue, 202, Laredo
For people in Laredo considering SPRAVATO®, the total cost may include both the medication and the supervised treatment and monitoring visit. Ask the treatment center how these services are billed and whether its estimate includes all visit-related charges. Coverage and your share of costs depend on your plan, benefits, treatment setting, and authorization requirements.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you took and how you responded. Ask your prescribing clinician to help gather those records, and find out who submits the authorization request. An authorization is not necessarily a guarantee that every charge will be paid.
Medicare may cover Spravato through Part B or Part D, depending on the plan and setting. Texas Medicaid coverage also depends on the plan and setting. The single Laredo center currently listed in this directory is recorded as not accepting Medicare or Medicaid; confirm its current policies directly. Its listing does not establish coverage under any commercial plan.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Eligibility and program terms must be checked; assistance should not be assumed.
Before starting, ask the center and insurer:
Request a written estimate and coverage explanation before committing to repeated visits.
SPRAVATO® treatment requires repeated visits to a healthcare setting certified through the SPRAVATO® REMS program. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never sent home with you. This directory currently lists one Laredo center offering Spravato, but its REMS certification status is not recorded. Confirm certification and appointment availability directly before making plans.
The typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber determines the schedule that fits your treatment; do not assume a fixed long-term calendar.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and any additional observation needed. Ask the center how much time to reserve. Discuss time off work, childcare, and other responsibilities before starting, especially during the early weeks.
Arrange for someone else to take you home after every session. You must not drive or operate machinery until the next day after a restful sleep. Ask about the center’s pickup and escort requirements before relying on a rideshare or other transportation service. Having a backup ride can help prevent last-minute cancellations.
If no Laredo center is listed when you search, or the listed option cannot meet your needs, this directory also lists centers in San Antonio, Austin, and Houston. These are search options, not confirmed appointments or recommendations. Verify certification, insurance acceptance, scheduling, and transportation arrangements before considering treatment outside Laredo.
This directory lists one Laredo center offering SPRAVATO®, but its REMS certification status has not been recorded. Ask the center to confirm that it is currently REMS-certified to provide treatment. Also check whether it is accepting new patients and can provide an evaluation. A directory listing alone does not verify certification, appointment availability, or insurance coverage.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks before deciding whether it is appropriate.
Coverage depends on your plan and treatment setting, and prior authorization and records of earlier antidepressant trials are commonly requested. Medicare or Texas Medicaid may cover treatment in some circumstances. However, the listed Laredo center is recorded as not accepting either program. Confirm current acceptance with the center and ask your insurer about coverage for both medication and monitoring services.
You self-administer the nasal spray under direct observation in a REMS-certified healthcare setting. Staff monitor you for at least two hours afterward, including for sedation, dissociation, breathing problems, and blood pressure increases. Allow extra time for preparation and any longer observation needed. Someone else must take you home; you cannot drive until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medicines, and substance use openly so your clinician can assess risks and explain monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when that is clinically needed. Do not wait for a treatment-center appointment during a crisis. Call or text 988 for crisis support, or call 911 in an emergency or if you are in immediate danger.
Approved uses, nearby treatment centers, and medically sourced patient guides.